Carol Holman

1.3k total citations
33 papers, 907 citations indexed

About

Carol Holman is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Carol Holman has authored 33 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in Carol Holman's work include Multiple Myeloma Research and Treatments (8 papers), Viral-associated cancers and disorders (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Carol Holman is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Viral-associated cancers and disorders (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Carol Holman collaborates with scholars based in United States, China and Japan. Carol Holman's co-authors include Henry H. Balfour, Richard C. Brundage, Toshiro Niki, Valarie McCullar, Jeffrey S. Miller, Todd Lenvik, Mitsuomi Hirashima, Bruce R. Blazar, Sarah A. Cooley and Angela Panoskaltsis‐Mortari and has published in prestigious journals such as Nature Communications, Blood and Analytical Chemistry.

In The Last Decade

Carol Holman

32 papers receiving 894 citations

Peers

Carol Holman

ONCOL

IMMUN

PFM

EPIDE

Juliane S. Walz Germany

Paolo Peterlongo Italy

Sanjay Swaminathan Australia

Paul Vink Netherlands

Sami Remadi Switzerland

Sudhir Tauro United Kingdom

Eleonora Forte United States

Davide Carlei Italy

Keiko Hodohara Japan

Béatrice Clemenceau France

Juliane S. Walz Germany

Carol Holman

385 ×0.8

ONCOL

453 ×1.3

IMMUN

349 ×1.7

67 ×0.4

PFM

115 ×0.7

EPIDE

Citations per year, relative to Carol Holman Carol Holman (= 1×) peers Juliane S. Walz

Countries citing papers authored by Carol Holman

Since Specialization

Citations

This map shows the geographic impact of Carol Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Holman more than expected).

Fields of papers citing papers by Carol Holman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Holman. The network helps show where Carol Holman may publish in the future.

Co-authorship network of co-authors of Carol Holman

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Holman. A scholar is included among the top collaborators of Carol Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Holman. Carol Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dewberry, Lindel C., et al.. (2024). Urologic Presentation of Unicentric Pediatric Castleman Disease in the Setting of Acute Renal Colic. Urology. 186. 162–165.

Chopra, Saurav, Nitin J. Karandikar, & Carol Holman. (2023). Systematic Evaluation of Hematologic Parameters and Blood Smear Findings in Patients With SARS-CoV-2 vs Other Viral Respiratory Infections. American Journal of Clinical Pathology. 160(4). 331–334. 1 indexed citations

Holman, Carol, et al.. (2022). A thorny matter: Spur cell anemia. Annals of Hepatology. 28(1). 100771–100771. 5 indexed citations

Dong, Qianze, Yan Xiu, Yang Wang, et al.. (2022). HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia. Nature Communications. 13(1). 6107–6107. 21 indexed citations

Syrbu, Sergei, et al.. (2020). Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical HyperplasiaA Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin. American Journal of Clinical Pathology. 156(3). 409–426. 11 indexed citations

Maliske, Seth, et al.. (2018). Impact of Splenectomy on Post-Surgical Platelet Count. Blood. 132(Supplement 1). 4981–4981. 3 indexed citations

Gu, Chunyan, Xuefang Jing, Carol Holman, et al.. (2018). Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma. BMC Cancer. 18(1). 1152–1152. 21 indexed citations

Holman, Carol, Van S. Tompkins, Xuefang Jing, et al.. (2016). KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice. Blood Cancer Journal. 6(2). e398–e398. 15 indexed citations

Tompkins, Van S., Ramakrishna Sompallae, Susan A. Walsh, et al.. (2016). Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia. Blood Cancer Journal. 6(11). e488–e488. 2 indexed citations

10.

Rosenthal, Nancy S., Carol Holman, Sergei Syrbu, et al.. (2016). Leukemic Transdifferentiation of Follicular Lymphoma Into an Acute Histiocytic Leukemia in a 52-Year-Old Caucasian Woman. Laboratory Medicine. 47(2). 155–157. 4 indexed citations

11.

Han, Seong‐Su, Van S. Tompkins, Sang Woo Han, et al.. (2015). CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma. Experimental Hematology and Oncology. 4(1). 9–9. 10 indexed citations

12.

Gu, Chao, Ye Yang, Ramakrishna Sompallae, et al.. (2015). FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia. 30(4). 873–882. 40 indexed citations

13.

Hashem, Hasan, et al.. (2014). Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension with pigeon chest deformity. Pediatric Blood & Cancer. 61(8). 1460–1462. 5 indexed citations

14.

Tompkins, Van S., Guido Tricot, Carol Holman, et al.. (2014). Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma. Immunologic Research. 59(1-3). 188–202. 39 indexed citations

15.

Holman, Carol, et al.. (2012). Quantitative Epstein–Barr virus shedding and its correlation with the risk of post‐transplant lymphoproliferative disorder. Clinical Transplantation. 26(5). 741–747. 44 indexed citations

16.

Holman, Carol, et al.. (2011). Plasmablastic myeloma in ascitic fluid. Diagnostic Cytopathology. 40(9). 806–809. 2 indexed citations

17.

Wudhikarn, Kitsada, et al.. (2010). Post‐transplant lymphoproliferative disorders in lung transplant recipients: 20‐yr experience at the University of Minnesota. Clinical Transplantation. 25(5). 705–713. 29 indexed citations

18.

Wudhikarn, Kitsada, et al.. (2009). Adrenal extranodal NK/T‐cell lymphoma diagnosed by fine‐needle aspiration and cerebrospinal fluid cytology and immunophenotyping: A case report. Diagnostic Cytopathology. 37(9). 686–695. 20 indexed citations

19.

Balfour, Henry H., et al.. (2007). A virologic pilot study of valacyclovir in infectious mononucleosis. Journal of Clinical Virology. 39(1). 16–21. 57 indexed citations

20.

Balfour, Henry H., Carol Holman, David O. Schmeling, et al.. (2005). A Prospective Clinical Study of Epstein‐Barr Virus and Host Interactions during Acute Infectious Mononucleosis. The Journal of Infectious Diseases. 192(9). 1505–1512. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact